CBZ vs. SLNO

Last updated Apr 1, 2026

Compare and contrast key facts about CBIZ, Inc. (CBZ) and Soleno Therapeutics, Inc. (SLNO).

Performance

CBZ vs. SLNO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in CBIZ, Inc. (CBZ) and Soleno Therapeutics, Inc. (SLNO). The values are adjusted to include any dividend payments, if applicable.

CBZ vs. SLNO - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
CBZ CBIZ, Inc.	-46.78%	-38.35%	30.74%	33.60%	19.76%	47.01%	-1.30%	36.85%	27.51%	12.77%
SLNO Soleno Therapeutics, Inc.	-27.69%	3.00%	11.68%	1,932.83%	-67.80%	-78.76%	-34.35%	71.93%	-5.00%	-55.56%

Fundamentals

EPS CBZ : $1.63 SLNO : $0.39
PE Ratio CBZ : 16.42 SLNO : 85.34
PS Ratio CBZ : 0.64 SLNO : 9.36
Total Revenue (TTM) CBZ : $2.68B SLNO : $190.41M
Gross Profit (TTM) CBZ : $344.24M SLNO : $96.84M
EBITDA (TTM) CBZ : $445.55M SLNO : $9.41M

Returns By Period

In the year-to-date period, CBZ achieves a -46.78% return, which is significantly lower than SLNO's -27.69% return. Over the past 10 years, CBZ has outperformed SLNO with an annualized return of 10.22%, while SLNO has yielded a comparatively lower -9.78% annualized return.

CBZ

• 1D: -0.59%
• 1M: -6.25%
• YTD: -46.78%
• 6M: -49.30%
• 1Y: -64.61%
• 3Y*: -18.44%
• 5Y*: -4.09%
• 10Y*: 10.22%

SLNO

• 1D: 9.99%
• 1M: -14.31%
• YTD: -27.69%
• 6M: -50.47%
• 1Y: -53.14%
• 3Y*: 150.11%
• 5Y*: 11.25%
• 10Y*: -9.78%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

CBZ vs. SLNO — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CBZ

CBZ Risk / Return Rank: 3
CBZ Sharpe Ratio Rank: 1
CBZ Sortino Ratio Rank: 2
CBZ Omega Ratio Rank: 2
CBZ Calmar Ratio Rank: 6
CBZ Martin Ratio Rank: 3

SLNO

SLNO Risk / Return Rank: 10
SLNO Sharpe Ratio Rank: 8
SLNO Sortino Ratio Rank: 10
SLNO Omega Ratio Rank: 10
SLNO Calmar Ratio Rank: 12
SLNO Martin Ratio Rank: 10

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CBZ vs. SLNO - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for CBIZ, Inc. (CBZ) and Soleno Therapeutics, Inc. (SLNO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	CBZ	SLNO	Difference
Sharpe ratio Return per unit of total volatility	-1.26	-0.83	-0.43
Sortino ratio Return per unit of downside risk	-2.15	-1.09	-1.06
Omega ratio Gain probability vs. loss probability	0.71	0.86	-0.15
Calmar ratio Return relative to maximum drawdown	-0.94	-0.81	-0.13
Martin ratio Return relative to average drawdown	-1.84	-1.51	-0.33
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

CBZ vs. SLNO - Sharpe Ratio Comparison

The current CBZ Sharpe Ratio is -1.26, which is lower than the SLNO Sharpe Ratio of -0.83. The chart below compares the historical Sharpe Ratios of CBZ and SLNO, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	CBZ	SLNO	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-1.26	-0.83	-0.43
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.12	0.05	-0.17
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.34	-0.05	+0.39
Sharpe Ratio (All Time) Calculated using the full available price history	0.16	-0.09	+0.25

Correlation

The correlation between CBZ and SLNO is 0.08, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

CBZ vs. SLNO - Dividend Comparison

Neither CBZ nor SLNO has paid dividends to shareholders.

Tickers have no history of dividend payments

Drawdowns

CBZ vs. SLNO - Drawdown Comparison

The maximum CBZ drawdown since its inception was -96.13%, roughly equal to the maximum SLNO drawdown of -99.86%. Use the drawdown chart below to compare losses from any high point for CBZ and SLNO.

Drawdown Indicators

	CBZ	SLNO	Difference
Max Drawdown Largest peak-to-trough decline	-96.13%	-99.86%	+3.73%
Max Drawdown (1Y) Largest decline over 1 year	-68.43%	-66.04%	-2.39%
Max Drawdown (5Y) Largest decline over 5 years	-71.64%	-95.49%	+23.85%
Max Drawdown (10Y) Largest decline over 10 years	-71.64%	-99.13%	+27.49%
Current Drawdown Current decline from peak	-69.71%	-94.90%	+25.19%
Average Drawdown Average peak-to-trough decline	-50.96%	-90.57%	+39.61%
Ulcer Index Depth and duration of drawdowns from previous peaks	34.96%	35.50%	-0.54%

Volatility

CBZ vs. SLNO - Volatility Comparison

The current volatility for CBIZ, Inc. (CBZ) is 14.91%, while Soleno Therapeutics, Inc. (SLNO) has a volatility of 17.95%. This indicates that CBZ experiences smaller price fluctuations and is considered to be less risky than SLNO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	CBZ	SLNO	Difference
Volatility (1M) Calculated over the trailing 1-month period	14.91%	17.95%	-3.04%
Volatility (6M) Calculated over the trailing 6-month period	39.25%	50.62%	-11.37%
Volatility (1Y) Calculated over the trailing 1-year period	51.33%	64.08%	-12.75%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	32.88%	243.38%	-210.50%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	30.20%	185.10%	-154.90%

Financials